[1]张 姝.血必净联合激素在脓毒血症急诊处理中的疗效研究[J].医学信息,2022,35(19):89-91.[doi:10.3969/j.issn.1006-1959.2022.19.024]
　ZHANG Shu.Study on Curative Effect of Xuebijing Combined with Hormone in Emergency Treatment of Sepsis[J].Journal of Medical Information,2022,35(19):89-91.[doi:10.3969/j.issn.1006-1959.2022.19.024]
点击复制

血必净联合激素在脓毒血症急诊处理中的疗效研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年19期
页码:
89-91
栏目:
论著
出版日期:
2022-10-01

文章信息/Info

Title:
Study on Curative Effect of Xuebijing Combined with Hormone in Emergency Treatment of Sepsis
文章编号:
1006-1959（2022）19-0089-03
作者:
张 姝
（天津医科大学总医院急诊医学科，天津 300052）
Author(s):
ZHANG Shu
(Department of Emergency Medicine,Tianjin Medical University General Hospital,Tianjin 300052,China)
关键词:
血必净; 激素; 脓毒血症; 急诊处理
Keywords:
Xuebijing; Hormone; Sepsis; Emergency treatment
分类号:
R459.7
DOI:
10.3969/j.issn.1006-1959.2022.19.024
文献标志码:
A
摘要:
目的 研究血必净联合激素治疗脓毒血症的急诊处理疗效。方法 选取2018年3月-2021年6月在我院诊治的46例脓毒血症患者为研究对象，采用随机数字表法分为对照组和观察组，各23例。对照组给予常规治疗和氢化可的松治疗，观察组在对照组基础上给予血必净治疗，比较两组治疗总有效率、炎症因子水平、并发症发生率、急性生理学及慢性健康状况（APACHEⅡ）评分及30 d存活率。结果 观察组治疗总有效率为91.30%，高于对照组的82.61%（P＜0.05）；两组治疗后C-反应蛋白（CRP）、降钙素原（PCT）、白细胞计数（WBC）均低于治疗前，且观察组低于对照组（P＜0.05）；观察组并发症发生率为8.70%，与对照组的13.04%比较，差异无统计学意义（P＞0.05）；两组治疗后APACHEⅡ评分均低于治疗前，且观察组低于对照组（P＜0.05）；观察组30 d存活率为95.65%，与对照组的86.95%比较，差异无统计学意义（P＞0.05）。结论 血必净联合激素在脓毒血症急诊处理中具有确切的效果，可提高治疗有效率，减轻炎症因子水平，减少并发症发生，存活率高，是一种安全、有效的处理方法，值得临床应用。
Abstract:
Objective To study the emergency treatment effect of Xuebijing combined with hormone in the treatment of sepsis.Methods A total of 46 patients with sepsis diagnosed and treated in our hospital from March 2018 to June 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 23 cases in each group. The control group was treated with routine treatment and hydrocortisone, and the observation group was treated with Xuebijing on the basis of the control group. The total effective rate, inflammatory factor level, complication rate, acute physiology and chronic health status (APACHEⅡ) score and 30-day survival rate were compared between the two groups.Results The total effective rate of treatment in the observation group was 91.30%, which was higher than 82.61% in the control group (P<0.05). After treatment, C-reactive protein (CRP), procalcitonin (PCT) and white blood cell count (WBC) in the two groups were lower than those before treatment, and those in the observation group were lower than the control group (P<0.05). The incidence of complications in the observation group was 8.70%, which was compared with 13.04% in the control group, the difference was not statistically significant (P>0.05). The APACHE II scores of the two groups after treatment were lower than those before treatment, and the observation group was lower than the control group (P<0.05). The 30-day survival rate of the observation group was 95.65%, which was compared with 86.95% of the control group, the difference was not statistically significant (P>0.05).Conclusion Xuebijing combined with hormone has definite effect in emergency treatment of sepsis, which can improve the effective rate of treatment, reduce the level of inflammatory factors, reduce the incidence of complications, and high survival rate. It is a safe and effective treatment method, which is worthy of clinical application.

参考文献/References:

[1]黄立锋,姚咏明,董宁,等.血浆凝溶胶蛋白水平对严重烧伤脓毒血症患者预后的意义[J].中华烧伤杂志,2016,32(2):77-81.[2]陈晓军,汪晓华.肝素结合蛋白与降钙素原检测在脓毒症患者预后评估中的作用比较[J].中国基层医药,2016,23(2):182-184.[3]吴晓文,李军,尧国胜,等.连续性肾脏替代疗法治疗脓毒症的疗效及其对微循环状态的影响[J].广西医学,2017,39(9):1295-1298.[4]任志文,赵冬,刘祺,等.下调miR-210的表达对U87细胞增殖、侵袭及凋亡的影响[J].郑州大学学报(医学版),2017,52(2):178-183.[5]曾佩,石酝琦.低剂量甲泼尼龙治疗脓毒血症的疗效及其对患者免疫功能的影响[J].海南医学,2017,28(5):726-728.[6]徐佳元,杨卫良.低剂量甲泼尼龙治疗急性化脓性骨髓炎伴脓毒血症对T淋巴细胞亚群凋亡的影响[J].中国矫形外科杂志,2016,24(9):836-838.[7]陈文冲,阿不力米提.甲泼尼龙治疗严重脓毒症的临床研究[J].现代药物与临床,2016,31(2):224-227.[8]薛骅,鲁丽利,向辉,等.乌司他丁联合氢化可的松治疗重症脓毒血症休克的疗效及对血清因子的影响[J].中国临床药理学与治疗学,2019,24(3):313-317.[9]伍增龙,黄永鹏,马俊,等.不同方法补充小剂量糖皮质激素对ICU顽固性脓毒性休克患者血流动力学血糖波动及预后的影响[J].山西医药杂志,2017,46(1):6-9.[10]曹钰,柴艳芬,邓颖,等.中国脓毒症/脓毒性休克急诊治疗指南(2018)[J].临床急诊杂志,2018,19(9):567-588.[11]张杰,叶慧芳,单艳华.还原型谷胱甘肽联合乌司他汀治疗感染性休克患者血清BNP、PCT水平及生活质量的影响[J].医药论坛杂志,2017,38(12):154-156.[12]夏胜兵,张国秀.高剂量与常规剂量乌司他丁联合血必净治疗脓毒症的临床疗效分析[J].第三军医大学学报,2018,40(16):84-89.[13]刘端绘,刘俊,莫毅,等.血必净注射液治疗脓毒症疗效观察[J].医学综述,2016,22(1):161-163.[14]刘凯,尚莉莉,蔡国锋,等.血必净中药组方对脓毒血症患者CRP、PCT水平的影响[J].中医药导报,2016,23(24):100-102.[15]裴储红,陈静.血必净治疗感染性休克的疗效及对血清CRP、PCT的影响[J].中国处方药,2017,15(8):83-84.[16]张宏,丁科.乌司他丁与还原型谷胱甘肽配合抗感染治疗对急诊脓毒血症伴感染性休克患者的疗效及其对氧化应激反应的影响[J].抗感染药学,2018,15(7):146-148.[17]朱永,李娜,陈民科,等.血必净联合常规西药治疗严重脓毒血症的临床疗效观察[J].中药药理与临床,2016,32(2):199-201.[18]卢静,肖斌,苏天生,等.血必净联合乌司他丁对脓毒症心肌损伤的保护效应[J].现代中西医结合杂志,2018,27(24):2653-2656.

相似文献/References:

[1]赵建美,邵 岩.血必净治疗社区获得性肺炎的研究进展[J].医学信息,2018,31(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
　ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Journal of Medical Information,2018,31(19):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
[2]刘红星,刘金凤,白 灵.地黄叶总苷胶囊治疗糖尿病女性性功能障碍的临床研究[J].医学信息,2018,31(09):87.[doi:10.3969/j.issn.1006-1959.2018.09.026]
　LIU Hong-xing,LIU Jin-feng,BAI Ling.Clinical Study on Treatment of Diabetic Female Sexual Dysfunction with Rehmannia Total Glycoside Capsule[J].Journal of Medical Information,2018,31(19):87.[doi:10.3969/j.issn.1006-1959.2018.09.026]
[3]张恺悦,陈幼琼.乌司他丁联合血必净对烧伤后脓毒症患者凝血功能及全身炎性反应的影响研究[J].医学信息,2019,32(04):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
　ZHANG Kai-yue,CHEN You-qiong.Effect of Ulinastatin Combined with Xuebijing on Coagulation Function and Systemic Inflammatory Response in Patients with Sepsis after Burn[J].Journal of Medical Information,2019,32(19):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
[4]王镜媛,寿松涛.血必净联合胸腺肽α1治疗重症肺炎合并脓毒症的效果[J].医学信息,2020,33(16):169.[doi:10.3969/j.issn.1006-1959.2020.16.056]
　WANG Jing-yuan,SHOU Song-tao.The Effect of Xuebijing Combined with Thymosin α1 in the Treatment of Severe Pneumonia Complicated with Sepsis[J].Journal of Medical Information,2020,33(19):169.[doi:10.3969/j.issn.1006-1959.2020.16.056]
[5]邓 伟.血必净注射液预防STEMI患者直接介入治疗后冠脉无复流的效果[J].医学信息,2020,33(17):163.[doi:10.3969/j.issn.1006-1959.2020.17.049]
　DENG Wei.Effect of Xuebijing Injection in Preventing Coronary Artery No-reflow After Direct Interventional Therapy in STEMI Patients[J].Journal of Medical Information,2020,33(19):163.[doi:10.3969/j.issn.1006-1959.2020.17.049]
[6]王 凯,田国栋.连续血液净化联合血必净对ARDS患者氧化应激、APACHEⅡ评分的影响[J].医学信息,2021,34(22):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]
　WANG Kai,TIAN Guo-dong.Effect of Continuous Blood Purification Combined with Xuebijing on Oxidative Stress and APACHEⅡ Score in ARDS Patients[J].Journal of Medical Information,2021,34(19):130.[doi:10.3969/j.issn.1006-1959.2021.22.040]
[7]张文旭,徐 绸.血必净联合连续肾脏替代治疗对感染性休克患者的疗效及对血液循环状态的影响[J].医学信息,2022,35(04):153.[doi:10.3969/j.issn.1006-1959.2022.04.040]
　ZHANG Wen-xu,XU Chou.Effect of Xuebijing Combined with Continuous Renal Replacement Therapy on Patientswith Septic Shock and its Effect on Blood Circulation[J].Journal of Medical Information,2022,35(19):153.[doi:10.3969/j.issn.1006-1959.2022.04.040]

更新日期/Last Update: 1900-01-01